Table 3.
Univariant analysis of risk factors for the post-TACE AKI
| Parameters | β-Coefficiency | S.E. | Wals | OR (95% C.I.) | Sig. |
|---|---|---|---|---|---|
| Gender | -0.142 | 0.461 | 0.095 | 0.867 (0.351-2.142) | 0.757 |
| Age | 0.23 | 0.014 | 2.835 | 1.024 (0.996-1.052) | 0.092 |
| Hypertension | 0.515 | 0.565 | 0.830 | 1.674 (0.553-5.068) | 0.362 |
| Diabetes | -0.654 | 0.745 | 0.771 | 0.520 (0.121-2.239) | 0.380 |
| NSAIDs | 0.283 | 0.328 | 0.745 | 1.327 (0.698-2.532) | 0.388 |
| Diuretics | 1.010 | 0.344 | 8.608 | 2.745 (1.398-5.390) | 0.003 |
| No. of intervention | 0.145 | 0.140 | 1.070 | 0.865 (0.658-1.138) | 0.301 |
| Epirubicin | -0.013 | 0.012 | 1.153 | 0.987 (0.963-1.011) | 0.283 |
| Radiocontrast agent | -0.013 | 0.007 | 3.267 | 0.987 (0.972-1.001) | 0.071 |
| Hemoglobin | -0.016 | 0.009 | 3.598 | 0.984 (0.968-1.001) | 0.058 |
| Hemocrat | -0.051 | 0.030 | 2.895 | 0.950 (0.895-1.008) | 0.089 |
| Total bilirubin | 0.203 | 0.082 | 6.081 | 1.225 (1.043-1.440) | 0.014 |
| Serum albumin | -0.053 | 0.033 | 2.666 | 0.948 (0.890-1.011) | 0.103 |
| BUN | 0.049 | 0.023 | 4.635 | 1.050 (1.004-1.099) | 0.031 |
| Uric acid | 0.372 | 0.096 | 15.065 | 1.450 (1.202-1.750) | 0.000 |
| Creatinine | 1.480 | 0.614 | 5.816 | 4.392 (1.319-14.619) | 0.016 |
| CO2 | -0.111 | 0.061 | 3.267 | 0.895 (0.794-1.009) | 0.071 |
| Serum Na+ | -0.028 | 0.048 | 0.343 | 0.973 (0.886-1.068) | 0.558 |
| PT time | 0.941 | 0.774 | 1.477 | 2.563 (0.562-11.696) | 0.224 |
| Child-Pugh score | 1.318 | 0.336 | 15.413 | 1.450 (1.202-1.750) | 0.000 |
| Proteinuria | 0.873 | 0.379 | 5.302 | 2.136 (0.926-4.926) | 0.021 |
| Hematuria | 0.759 | 0.426 | 3.167 | 0.807 (0.475-1.372) | 0.075 |
| Urine pH | -0.214 | 0.270 | 0.627 | 0.807 (0.475-1.372) | 0.428 |
| Postoperative fluid infusion | -0.477 | 0.293 | 2.655 | 0.621 (0.350-1.102) | 0.103 |
| Lipiodol | 0.006 | 0.019 | 0.103 | 1.006 (0.970-1.044) | 0.749 |
S.E., standard error; Wals, Walds statistics; OR, odds ratio; C.I., confidence interval; Sig., significance.